What is Influenza Vaccine (CPT 90694)?

Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage. This clinical code is utilized across practices and hospitals for diagnostic and therapeutic service documentation.

What do doctors typically charge for Influenza Vaccine?

The nationwide median physician charge for Influenza Vaccine (CPT 90694) is $77.55. Doctor billed charges vary based on geographic region, setting, and overhead.

What is the standard insurance baseline for CPT 90694?

The standard insurance baseline reimbursement rate is $75.49. This represents the customary allowable amount established across standard fee schedules.

Home/Procedures/Influenza Vaccine

CPT 90694Medical Service

Influenza Vaccine

Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage. Clinical pricing breakdown and utilization metrics across 51,679 practicing doctors nationwide.

$77.55

Peer Median Charge

Gross billed rate

$75.49

Standard Baseline

Customary allowable

1.0x

National Markup

Charge vs baseline

51,679

Active Physicians

Billing this code

Planning care or already received a bill for CPT 90694?Calculate total facility bundle costs or generate an assertive dispute settlement offer.

Calculate Bundled Cost →Dispute an Inflated Bill 🧾

Understanding This Medical Fee

Gross Charge vs Negotiated Payment: The median physician charge for this service is $77.55. However, insured patients almost never pay this full amount directly. Insurers negotiate rates down toward the $75.49 baseline.

Self-Pay & Uninsured Guidance: If you are paying without insurance or out-of-network, request a prompt-pay cash discount. Most medical practices are willing to settle self-pay bills near the customary baseline rate rather than the full gross charge.

Key Questions for Your Doctor's Billing Office:

"Does Dr. [Name] participate in my specific insurance plan network?"
"What is the total self-pay or cash rate for code 90694 if paid upfront?"
"Are there separate facility, anesthesia, or pathology fees associated with this procedure?"